Treatment Options for Children and Adolescents with Hodgkin Lymphoma
Low-Risk Childhood Hodgkin Lymphoma
Intermediate-Risk Childhood Hodgkin Lymphoma
High-Risk Childhood Hodgkin Lymphoma
Nodular Lymphocyte Predominant Childhood Hodgkin Lymphoma
A link to a list of current clinical trials is included for each treatment section. For some types or stages of cancer, there may not be any trials listed. Check with your doctor for clinical trials that are not listed here but may be right for you.
Low-Risk Childhood Hodgkin Lymphoma
Treatment of low-risk childhood Hodgkin lymphoma may include the following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I childhood Hodgkin lymphoma and stage II childhood Hodgkin lymphoma.
Intermediate-Risk Childhood Hodgkin Lymphoma
Treatment of intermediate-risk childhood Hodgkin lymphoma may
include the following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I childhood Hodgkin lymphoma, stage II childhood Hodgkin lymphoma, stage III childhood Hodgkin lymphoma and stage IV childhood Hodgkin lymphoma.
High-Risk Childhood Hodgkin Lymphoma
Treatment of high-risk childhood Hodgkin lymphoma may include
intensive or high-dose combination chemotherapy with low- dose radiation therapy to
involved areas.
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage III childhood Hodgkin lymphoma and stage IV childhood Hodgkin lymphoma.
Nodular Lymphocyte Predominant Childhood Hodgkin Lymphoma
Treatment of nodular lymphocyte predominant childhood Hodgkin lymphoma may include the
following:
Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with childhood nodular lymphocyte predominant Hodgkin lymphoma.
Back to Top
< Previous Section | Next Section > |